Qiming Venture Partners

  • New Horizon Health raises USD20m in Series D round

    China’s early-stage cancer screening biotech company New Horizon Health announced that it has raised 20 million US dollars in a Series D financing round, led by private equity fund Omniscience. American Exome Asset Management, and existing investor Qiming Venture Partners, SBCVC and Duke Management Company also participated in the round.